Adma Biologics Stock Price

-0.035 (-2.71%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Adma Biologics Inc ADMA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.035 -2.71% 1.255 14:20:24
Open Price Low Price High Price Close Price Prev Close
1.23 1.215 1.30 1.29
Bid Price Ask Price Spread News
1.25 1.26 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,550 1,730,858 $ 1.26 $ 2,186,085 - 1.15 - 3.1105
Last Trade Time Type Quantity Stock Price Currency
14:20:24 100 $ 1.255 USD


Draw Mode:

Adma Biologics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 166.63M 132.77M 109.16M $ 42.22M $ - -0.88 -1.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.78M 0.70%

more financials information »

Adma Biologics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADMA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.171.301.151.211,961,9500.0857.26%
1 Month1.221.421.151.214,378,7510.0352.87%
3 Months1.741.751.151.353,144,575-0.485-27.87%
6 Months2.152.631.151.775,100,906-0.895-41.63%
1 Year2.353.11051.151.974,243,517-1.10-46.6%
3 Years6.517.041.152.592,607,620-5.26-80.72%
5 Years6.907.701.152.651,614,806-5.65-81.81%

Adma Biologics Description

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipate providing contract filling, labeling and packing services.

Your Recent History
Adma Biolo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.